Literature DB >> 23623837

Thyroid cancer: surgery for the primary tumor.

I J Nixon1, I Ganly, J P Shah.   

Abstract

Surgery is the mainstay of therapy for most patients who present with thyroid cancer. The surgeon must select an appropriate procedure based upon pre operative factors such as tumor histology, extent of primary disease, the presence of regional or distant metastases, associated disease in the contralateral thyroid lobe and the potential for post operative adjuvant therapy. Preservation of the vital structures in the central neck, including the recurrent and superior laryngeal nerves and the parathyroid glands is critical as is the maintenance of absolute hemostasis. In this review article we describe the management of Well Differentiated Thyroid Cancer (WDTC) presenting as a solitary nodule, WDTC in a background of multinodular disease and the management of WDTC presenting as advanced local disease. We go onto discuss the impact that regional and distant metastases have on the choice of surgical approach. The focus of this article is WDTC, however the principles of management of the primary in medullary and anaplastic carcinoma are also discussed.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23623837     DOI: 10.1016/j.oraloncology.2013.03.439

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  10 in total

1.  Current management of papillary thyroid microcarcinoma in Canada.

Authors:  Mazin Merdad; Antoine Eskander; John De Almeida; Jeremy Freeman; Lorne Rotstein; Shereen Ezzat; Anna M Sawka; David P Goldstein
Journal:  J Otolaryngol Head Neck Surg       Date:  2014-08-14

Review 2.  Diagnosis and treatment of patients with thyroid cancer.

Authors:  Quang T Nguyen; Eun Joo Lee; Melinda Gingman Huang; Young In Park; Aashish Khullar; Raymond A Plodkowski
Journal:  Am Health Drug Benefits       Date:  2015-02

3.  Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signaling.

Authors:  Zhiyan Zhao; James G Herman; Malcolm V Brock; Jindong Sheng; Meiying Zhang; Baoguo Liu; Mingzhou Guo
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

4.  Lymph Node Metastases Papillary Thyroid Carcinoma and their Importance in Recurrence of Disease.

Authors:  Sinisa Maksimovic; Branislava Jakovljevic; Zdenka Gojkovic
Journal:  Med Arch       Date:  2018-04

5.  Prognostic Impact of Direct 131I Therapy After Detection of Biochemical Recurrence in Intermediate or High-Risk Differentiated Thyroid Cancer: A Retrospective Cohort Study.

Authors:  José F Carrillo; Rafael Vázquez-Romo; Margarita C Ramírez-Ortega; Liliana C Carrillo; Edgar Gómez-Argumosa; Luis F Oñate-Ocaña
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-29       Impact factor: 5.555

6.  Silencing of LIM and SH3 Protein 1 (LASP-1) Inhibits Thyroid Cancer Cell Proliferation and Invasion.

Authors:  Wei Gao; Jiakai Han
Journal:  Oncol Res       Date:  2016-11-17       Impact factor: 5.574

7.  Incidence and Predictors of Synchronous Bone Metastasis in Newly Diagnosed Differentiated Thyroid Cancer: A Real-World Population-Based Study.

Authors:  Lin Qi; Wenchao Zhang; Xiaolei Ren; Ruiling Xu; Chaoqian Liu; Chao Tu; Zhihong Li
Journal:  Front Surg       Date:  2022-01-24

Review 8.  Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer.

Authors:  Massimiliano Pacilio; Miriam Conte; Viviana Frantellizzi; Maria Silvia De Feo; Antonio Rosario Pisani; Andrea Marongiu; Susanna Nuvoli; Giuseppe Rubini; Angela Spanu; Giuseppe De Vincentis
Journal:  Diagnostics (Basel)       Date:  2022-07-21

9.  Zinc finger E-box-binding homeobox 1: its clinical significance and functional role in human thyroid cancer.

Authors:  Yan Zhang; Gang Liu; Shihe Wu; Futing Jiang; Jiangping Xie; Yuhong Wang
Journal:  Onco Targets Ther       Date:  2016-03-29       Impact factor: 4.147

10.  Diffusion-Weighted Imaging Using a Readout-Segmented, Multishot EPI Sequence at 3 T Distinguishes between Morphologically Differentiated and Undifferentiated Subtypes of Thyroid Carcinoma-A Preliminary Study.

Authors:  Stefan Schob; Peter Voigt; Lionel Bure; Hans-Jonas Meyer; Claudia Wickenhauser; Curd Behrmann; Annekathrin Höhn; Paul Kachel; Henning Dralle; Karl-Titus Hoffmann; Alexey Surov
Journal:  Transl Oncol       Date:  2016-09-20       Impact factor: 4.243

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.